---
schema_version: "secwatch.filing_event.v1"
accession: "0001021771-25-000066"
form_type: "8-K"
ticker: "BRTX"
cik: "0001505497"
company_name: "BioRestorative Therapies, Inc."
filed_at: "2025-03-27T23:59:59+00:00"
generated_at: "2026-05-24T03:52:09.305104+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "low"
source: SEC EDGAR
---

# BioRestorative Therapies to release FY2024 results after market close on March 27, 2025, with conference call

## Summary
- Financial results for year ended Dec 31, 2024 will be released after market close on March 27, 2025.
- Management will host a conference call following the release to review results and provide a business update.
- Conference call details (dial-in, replay) were not included in the filing; no financial figures provided.

## SEC filing metadata
- accession: 0001021771-25-000066
- form_type: 8-K
- ticker: BRTX
- cik: 0001505497
- company_name: BioRestorative Therapies, Inc.
- filed_at: 2025-03-27T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: low
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1505497/000102177125000066/0001021771-25-000066-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1505497/000102177125000066/brt8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001021771-25-000066
- JSON: https://secwatch.observer/filing/0001021771-25-000066.json
- Plain text: https://secwatch.observer/filing/0001021771-25-000066.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.